Healthcare Sales & Marketing Network News: ZYBRESTAT

Searching News Database: ZYBRESTAT

HSMN NewsFeed - 16 May 2014
OXiGENE Names Experienced Biotech Executive, David J. Chaplin, Ph.D., as President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 21 Nov 2012
OXiGENE Announces OXi4503 Granted Orphan Designation for Treatment of Acute Myelogenous Leukemia
Biopharmaceuticals Oncology

HSMN NewsFeed - 11 Feb 2010
OXiGENE Announces Restructuring to Focus Resources on Key Programs and Provides Business Update
Biopharmaceuticals

HSMN NewsFeed - 23 Oct 2008
OXiGENE, Inc. Names John A. Kollins as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Dec 2007
OXiGENE Reports Positive Results in Phase 2 Study of ZYBRESTAT(TM) in Platinum-Resistant Ovarian Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 31 Jul 2007
OXiGENE Appoints Patricia Walicke, M.D., Ph.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 May 2007
OXiGENE Reaches Agreement with FDA on Special Protocol Assessment for ZYBRESTAT(TM) (CA4P) Phase II/III Pivotal Trial in Anaplastic Thyroid Cancer
Biopharmaceuticals Oncology

Return to NewsFeed

FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!